D'Orazio & Associates’s NeoGenomics NEO Stock Holding History

D'Orazio & Associates’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-500	Closed	-$14K	–	355
2020 Q1	$14K	Hold	500	–	–	0.01%	207
2019 Q4	$15K	Buy	+500	New	+$11.9K	﹤0.01%	230

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D'Orazio & Associates's NEO Position: Q2 2020 in Review

D'Orazio & Associates sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 500 shares — an estimated $14K sold.

D'Orazio & Associates first reported a position in NEO in Q4 2019 and held it in 2 quarters. The position peaked at $15K in Q4 2019. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

D'Orazio & Associates reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
D'Orazio & Associates sold 500 NeoGenomics shares in Q2 2020, an estimated $14K.
D'Orazio & Associates first reported a position in NeoGenomics in Q4 2019 and held it in 2 quarters.
D'Orazio & Associates's NeoGenomics position peaked at $15K in Q4 2019.
285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on D'Orazio & Associates's 13F filing for Q2 2020, filed 22 Jul 2020.